This message was sent to ##Email##
We are pleased to welcome the newest members of the AFMR!
Joshi Aditya Anantrao
Mohammad Tarek Kabbany
Jorge Mejia Corletto
Muhammad Salman Janjua
Juan Nieves Rivera
Stefanie Perez Juanazo
Nesrin Yurttutan Engin
The AFMR would like to recognize Wenjun Deng, PhD as the 2016 Henry Christian Award winner for her outstanding abstract titled, “Important Role of Prothrombin Time (PT) and Partial Thromboplastin Time (PTT) in Predicting TPA-Related Hemorrhagic Transformation.”
The AFMR is sponsoring two Symposia during Experimental Biology 2016 which will be held from April 2-6, 2016 in San Diego, California. Over 14,000 physicians, scientists, and healthcare professionals are expected to attend this very prestigious multidisciplinary scientific meeting. We look forward to seeing you there!
Emerging New Mechanism in Alcoholic Liver Disease
Wednesday, April 6, 10:30AM - 12:30PM, Room 23
Chaired by Suthat Liangpunsakul, MD, MPH of Division of Gastroenterology and Hepatology, Indiana University School of Medicine
Natural Products: Biological Effects and Therapeutic Potential in Human Disease
Wednesday, April 6, 2016 from 2:30PM-4:30PM, Room 25A
Chaired by Sharma S Prabhakar, MD, MBA, FACP of Texas Tech University Health Sciences Center and Dayong Wu, MD, PhD of Friedman School of Nutrition Science and Policy, Tufts University
Are you ready to learn about the latest discoveries in the field of translational science? We're bringing together leading minds in the field to update you on hot topics and teach you how to take your research to the next level!
Dr. Steven Small completed his undergraduate training in mathematics at Dartmouth College, his Ph.D. in cognitive science and artificial intelligence (Computer Science) at the University of Maryland, and his M.D. at the University of Rochester School of Medicine and Dentistry. He completed a residency in neurology at the University of Pittsburgh, where he served as Chief Resident. He was recruited to The University of Chicago in 1999 to found the Brain Research Imaging Center, which he directed from its inception in 2000 until 2006, and to the University of California, Irvine in 2010 to become the fourth Chair of the Department of Neurology and the first Stanley van den Noort Endowed Professor.
Plan to attend Translational Science 2016, April 13-15, 2016 at the Omni Shoreham Hotel in Washington, DC!
Translational Science 2016 is jointly sponsored by the Association for Clinical and Translational Science (ACTS), American Federation for Medical Research (AFMR) and Clinical Research Forum (CR Forum). To learn more about the Translational Science 2016 partners, click here.
Save-the-Date: join us at the Western Regional Medical Conference (formerly known as the Western Regional Meeting), January 26-28, 2017 in Carmel California.
Save-the-Date: Join us at the Southern Regional Meeting, February 16-18, 2017 in New Orleans, Louisiana.
The leadership of the Central Society for Clinical and Translational Research (CSCTR) and the Midwestern Section of the American Federation for Medical Research (MWAFMR) invite you to participate in the 2016 Combined Annual Meeting. The Combined Annual Meeting has a rich annual tradition of providing a forum for young investigators, fellows and associate/assistant professors to present their research to leaders in their fields. This is one of the few multispecialty meetings with a broad focus where the attendees can learn about research techniques used in other medical specialties and apply those techniques to their own research. We are pleased to honor the 2016 MWAFMR Scholar Awardees:
Congratulations to them! We are also pleased to confirm that Dr. Michael Ison of the Northwestern University Feinberg School of Medicine will be the Keynote Speaker during the 2016 Combined Annual Meeting. The speakers for the Career Development Workshop will be Dr. Karen Horowitz of Case Western Reserve University and Dr. Amir K Jaffer of Rush University Medical Center.
The 2016 Eastern Regional Meeting of the American Federation for Medical Research will take place Thursday, April 13, 2016, at the Omni Shoreham in Washington, DC. View the online program and register today! Check out the 2016 Eastern Region Scholars! The Scholar Awardees have the highest scoring abstracts and are recognized for their outstanding work at the upcoming regional meeting. View the scholars here.
Benefits of membership include:
AFMR programs offer members many opportunities to network with other clinician-scientists within their chosen field. Join today and become a part of the organization devoted to the best interests of you- the modern day medical researcher.
- Subscription to the Journal of Investigative Medicine (JIM)
- Discounted fees to publish in the Journal of Investigative Medicine High Impact Case Reports
- Eligibility to apply for AFMR Foundation awards
- Ability to participate on AFMR councils, committees, and FASEB activities
- Discounted registration rates at AFMR national and regional meetings
As you review your annual giving for the upcoming year, I would like to ask you to consider a gift to the American Federation for Medical Research. Your contribution will be used to support AFMR-sponsored activities and we need your support.
With your generous donation, we can continue to offer innovative programs to help our members advance their careers at government facilities; medical centers; universities and medical schools; research institutions; and private industry in all 50 states and throughout the world. The AFMR provides young and aspiring trainees with scholarships and travel grants to attend regional meetings offering them the opportunity to present their findings to their peers and receive the guidance of senior scientists. The AFMR also recognizes trainees with national awards, such as the Henry Christian awards, named after the founder of the organization, Dr. Henry Christian. The AFMR strives to foster the development of future generations of clinical scientists and investigators through its initiatives, while encouraging public, private, and governmental investment in the development of these individuals.
Contributions are tax-deductible. Whether you choose to contribute $50, $100, $250, or another amount, I urge you to participate. I also welcome your suggestions or ideas about other potential sponsors for our programs. Most importantly, we thank you if you made a donation in 2015.
Please click here if you would like to make an online donation.
Leticia M. Ryan, MD, MPH
Dr. Francis Collins and NIH’s senior leadership published a letter in Science reinforcing NIH’s commitment to basic science and introducing a revision to our grant application instructions. The updated instructions will ensure that the public health relevance statement in grant applications better reflects the full spectrum of the NIH mission and its commitment to support a robust, diverse research portfolio, including pursuit of basic knowledge.
We encourage you to share the letter with interested members of your research communities.
The New England Journal of Medicine
There is concern that antidiabetic incretin-based drugs, including dipeptidyl peptidase 4 (DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) analogues, can increase the risk of heart failure. Ongoing clinical trials may not have large enough samples to effectively address this issue.
By Denise Valenti
Several researchers within the field of Alzheimer's disease recently expressed their opinion regarding the role of microbes in the development of the disease. These voices cannot be ignored given that 33 professionals from 10 different countries contributed. The opinion review expressed an alarm and concern that, despite the hundreds of studies on humans indicating a role of microbes in the degeneration of the aging brain, the area of work remains largely ignored.
Targeted, temporally regulated neural modulation is invaluable in determining the physiological roles of specific neural populations or circuits. Here we describe a system for non-invasive, temporal activation or inhibition of neuronal activity in vivo and its use to study central nervous system control of glucose homeostasis and feeding in mice.
By Dorothy L. Tengler
Childhood brain tumors are the second-most frequent malignancy of childhood and the most common form of solid tumor. A lack of treatment options keeps survival rates low. Unlike adults with brain cancer, children cannot receive radiation therapy, so physicians must rely on medications and other strategies. Even survivors often have severe neurologic, neurocognitive and psychosocial sequelae. But children with brain cancer may soon get some help from mice with the same disease.
The New England Journal of Medicine
Higher-than-normal levels of circulating triglycerides are a risk factor for ischemic cardiovascular disease. Activation of lipoprotein lipase, an enzyme that is inhibited by angiopoietin-like 4 (ANGPTL4), has been shown to reduce levels of circulating triglycerides.
| || |
Connect with AFMR
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Natalie Rodriguez, Assistant Executive Editor, 469-420-2635 | Contribute news
Elizabeth Chouinard, AFMR Executive Director, 978-927-8330 | www.afmr.org
Nicole Pinkham, AFMR Administrator, 978-927-8330 | www.afmr.org
American Federation for Medical Research
500 Cummings Center, Suite 4550 | Beverly, MA 01915 | 978-927-8330 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063